Abveris is a leading antibody discovery partner based in Boston and operates as a division of Twist Bioscience. Established in 2014, the company specializes in in vivo antibody discovery and collaborates with top biopharmaceutical scientists across various organizations. Their efforts focus on discovering and developing antibodies for pharmaceutical and industrial applications within the Biopharma, Biotechnology, and Pharmaceutical industries. Currently, there is no public information available regarding their latest investment round or investors.
There is no investment information
No recent news or press coverage available for Abveris.